Post by Jubilant Ingrevia Limited

As small molecule pipelines become more complex, the need for CDMO partners who can combine regulatory readiness, scale-up expertise and supply reliability has never been greater.   At CDMO Live Europe, we look forward to engaging with global pharma and biotech partners on enabling seamless clinical-to-commercial transitions for critical molecules.   At Jubilant Ingrevia, our integrated development-to-manufacturing platform supports small molecule NCEs across Phase I–III and commercial launches with strong cGMP manufacturing, robust quality systems and seamless tech transfer capabilities.   Looking forward to meaningful conversations at CDMO Live Europe. Amit Mishra Yuvraj B Manav Kataria Sonia Dharap   #CDMO #CDMOLive #SmallMolecules #PharmaManufacturing #cGMP #TechTransfer #LifeSciences #JubilantIngrevia